259 related articles for article (PubMed ID: 21345147)
1. Effects of Toll-like receptor signals in T-cell neoplasms.
Morrison C; Baer MR; Zandberg DP; Kimball A; Davila E
Future Oncol; 2011 Feb; 7(2):309-20. PubMed ID: 21345147
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
3. Increased Toll-Like Receptor-Myeloid Differentiation Factor 88 Expression at the Maternal-Fetal Interface Is Associated with Spontaneous Abortion.
He M; Zhou Y; Jiang M; Li F; Yang M; Fan Y; Deng D
Gynecol Obstet Invest; 2017; 82(6):553-562. PubMed ID: 28609762
[TBL] [Abstract][Full Text] [Related]
4. Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
Chen R; Alvero AB; Silasi DA; Steffensen KD; Mor G
Oncogene; 2008 Jan; 27(2):225-33. PubMed ID: 18176604
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-4 signaling in mantle cell lymphoma: effects on tumor growth and immune evasion.
Wang L; Zhao Y; Qian J; Sun L; Lu Y; Li H; Li Y; Yang J; Cai Z; Yi Q
Cancer; 2013 Feb; 119(4):782-91. PubMed ID: 22915070
[TBL] [Abstract][Full Text] [Related]
6. T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells.
Nouri Y; Weinkove R; Perret R
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34799397
[TBL] [Abstract][Full Text] [Related]
7. B cell intrinsic TLR signals amplify but are not required for humoral immunity.
Meyer-Bahlburg A; Khim S; Rawlings DJ
J Exp Med; 2007 Dec; 204(13):3095-101. PubMed ID: 18039950
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in T-cell lymphoid neoplasms.
Bigas A; Rodriguez-Sevilla JJ; Espinosa L; Gallardo F
Exp Hematol; 2022 Feb; 106():3-18. PubMed ID: 34879258
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors signaling: A complex network for NF-κB activation in B-cell lymphoid malignancies.
Ntoufa S; Vilia MG; Stamatopoulos K; Ghia P; Muzio M
Semin Cancer Biol; 2016 Aug; 39():15-25. PubMed ID: 27402288
[TBL] [Abstract][Full Text] [Related]
10. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
Kim EJ; Lee SM; Suk K; Lee WH
Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
[TBL] [Abstract][Full Text] [Related]
11. TLR Function in Murine CD4(+) T Lymphocytes and Their Role in Inflammation.
Flaherty S; Reynolds JM
Methods Mol Biol; 2016; 1390():215-27. PubMed ID: 26803632
[TBL] [Abstract][Full Text] [Related]
12. Role of Toll-like receptor/MYD88 signaling in neurodegenerative diseases.
Xiang W; Chao ZY; Feng DY
Rev Neurosci; 2015; 26(4):407-14. PubMed ID: 25870959
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
Gelman AE; Zhang J; Choi Y; Turka LA
J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
[TBL] [Abstract][Full Text] [Related]
14. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages.
Megías J; Yáñez A; Moriano S; O'Connor JE; Gozalbo D; Gil ML
Stem Cells; 2012 Jul; 30(7):1486-95. PubMed ID: 22511319
[TBL] [Abstract][Full Text] [Related]
15. Sensing of microbial molecular patterns by Toll-like receptors.
Song DH; Lee JO
Immunol Rev; 2012 Nov; 250(1):216-29. PubMed ID: 23046132
[TBL] [Abstract][Full Text] [Related]
16. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
Stoffels B; Hupa KJ; Snoek SA; van Bree S; Stein K; Schwandt T; Vilz TO; Lysson M; Veer CV; Kummer MP; Hornung V; Kalff JC; de Jonge WJ; Wehner S
Gastroenterology; 2014 Jan; 146(1):176-87.e1. PubMed ID: 24067878
[TBL] [Abstract][Full Text] [Related]
17. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.
Aumeunier A; Grela F; Ramadan A; Pham Van L; Bardel E; Gomez Alcala A; Jeannin P; Akira S; Bach JF; Thieblemont N
PLoS One; 2010 Jul; 5(7):e11484. PubMed ID: 20628601
[TBL] [Abstract][Full Text] [Related]
18. Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice.
Abdollahi-Roodsaz S; van de Loo FA; Koenders MI; Helsen MM; Walgreen B; van den Bersselaar LA; Arntz OJ; Takahashi N; Joosten LA; van den Berg WB
Arthritis Rheum; 2012 Jun; 64(6):1838-47. PubMed ID: 22147588
[TBL] [Abstract][Full Text] [Related]
19. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis.
Tomita T; Kanai T; Fujii T; Nemoto Y; Okamoto R; Tsuchiya K; Totsuka T; Sakamoto N; Akira S; Watanabe M
J Immunol; 2008 Apr; 180(8):5291-9. PubMed ID: 18390710
[TBL] [Abstract][Full Text] [Related]
20. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias.
Carbone A; Gloghini A; Zagonel V; Aldinucci D; Gattei V; Degan M; Improta S; Sorio R; Monfardini S; Pinto A
Blood; 1995 Dec; 86(12):4617-26. PubMed ID: 8541553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
